NEW YORK, Dec. 12, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Drug Delivery: Surveying the Global Competitive Landscape
http://www.reportlinker.com/p01054658/Drug-Delivery-Surveying-the-Global-Competitive-Landscape .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
The importance of drug delivery technology grows ever more acute; commercial and industry interest is continuing to build. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes, bringing new therapies to the market that would, previously, have been impossible to administer.
This new, richly-detailed report provides the most comprehensive review of the sector and examines the competitive drug delivery landscape with analysis of 112 key companies. The company landscape is always on the move: some have been bought by the big players, whilst others have just run out of money and gone to the wall. Slowly but surely the private equity groups - most of whom have been in relative hibernation for the past couple of years - are gradually returning to the fold and kick-starting the impetus for capital investment.
This report provides you with key data for each featured company...
Company Overview & Technology Focus
Key Personnel
Competition & Competing Products
Key Milestones
Products/Technologies
R&D & Research Strategy
Key Agreements & Alliances
Financial Data (where available)
Comprehensive Contact Details
The ability to readily assess the companies involved, research areas of interest, products being developed, strategic collaborations and performance is key to understanding this market. In 670+ information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape 2012 (published February 2012) evaluates companies large and small from multinationals to specialist development and technology businesses. All major technology areas such as Controlled-release, Nucleic acid, Nano-enabled and Targeted delivery are covered.
Related Publications
Drug Delivery Insight
Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.
Emerging Drug Delivery Technologies & Strategies: Players, Pipelines and Partnerships
This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.
Drug Delivery Technologies: Advanced Oral & Parenteral
This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.
Medical Device Companies Analysis
A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios.
This report details some of the most exciting technology out there and the companies involved.
Table of Contents
3M DRUG DELIVERY SYSTEMS 1
KEY PERSONNEL 1
COMPANY OVERVIEW1
KEY MILESTONES 1
PRODUCTS / TECHNOLOGIES2
AGREEMENTS6
KEY FINANCIAL DATA 7
COMPETITION 7
ACCESS PHARMACEUTICALS INC 9
KEY PERSONNEL 9
COMPANY OVERVIEW9
KEY MILESTONES 9
PRODUCTS / TECHNOLOGIES 10
RESEARCH ACTIVITIES 12
AGREEMENTS 15
KEY FINANCIAL DATA17
COMPETITION17
ACRUX LTD 19
KEY PERSONNEL 19
COMPANY OVERVIEW 19
KEY MILESTONES19
PRODUCTS / TECHNOLOGIES 20
RESEARCH ACTIVITIES 21
AGREEMENTS 21
KEY FINANCIAL DATA22
ACURA PHARMACEUTICALS23
KEY PERSONNEL 23
COMPANY OVERVIEW 23
KEY MILESTONES23
PRODUCTS / TECHNOLOGIES 23
RESEARCH ACTIVITIES 25
AGREEMENTS 25
KEY FINANCIAL DATA25
COMPETITION25
ALKERMES INC 27
KEY PERSONNEL 27
COMPANY OVERVIEW 27
KEY MILESTONES27
PRODUCTS / TECHNOLOGIES 28
PRODUCTS / TECHNOLOGIES (Elan Drug Technologies) 29
RESEARCH ACTIVITIES 32
AGREEMENTS 38
KEY FINANCIAL DATA39
COMPETITION39
ALLERGY THERAPEUTICS 41
KEY PERSONNEL 41
COMPANY OVERVIEW 41
KEY MILESTONES41
PRODUCTS / TECHNOLOGIES 42
RESEARCH ACTIVITIES44
AGREEMENTS44
KEY FINANCIAL DATA 45
COMPETITION 45
APRICUS BIOSCIENCES INC 47
KEY PERSONNEL 47
COMPANY OVERVIEW 47
KEY MILESTONES 47
PRODUCTS / TECHNOLOGIES48
RESEARCH ACTIVITIES 49
AGREEMENTS 50
KEY FINANCIAL DATA 51
COMPETITION 52
APTALIS PHARMA 53
KEY PERSONNEL 53
COMPANY OVERVIEW 53
KEY MILESTONES 53
PRODUCTS / TECHNOLOGIES54
AGREEMENTS 56
KEY FINANCIAL DATA 57
Aptar Group 59
KEY PERSONNEL 59
COMPANY OVERVIEW 59
KEY MILESTONES 59
PRODUCTS / TECHNOLOGIES 59
KEY FINANCIAL DATA 60
COMPETITION 60
ARADIGM CORPORATION 61
KEY PERSONNEL 61
COMPANY OVERVIEW 61
KEY MILESTONES 61
PRODUCTS / TECHNOLOGIES 62
RESEARCH ACTIVITIES 62
KEY FINANCIAL DATA 64
COMPETITION 64
ARCHIMEDES PHARMA 65
KEY PERSONNEL 65
COMPANY OVERVIEW 65
KEY MILESTONES 65
PRODUCTS / TECHNOLOGIES66
RESEARCH STRATEGY 68
AGREEMENTS68
KEY FINANCIAL DATA 69
ATLANTIC PHARMACEUTICALS 71
KEY PERSONNEL 71
COMPANY OVERVIEW 71
KEY MILESTONES 71
PRODUCTS / TECHNOLOGIES 71
KEY FINANCIAL DATA 72
COMPETITION 72
BAXA CORPORATION 73
KEY PERSONNEL 73
COMPANY OVERVIEW 73
KEY MILESTONES 73
PRODUCTS / TECHNOLOGIES 74
AGREEMENTS 76
KEY FINANCIAL DATA 76
BAXTER INTERNATIONAL INC 77
KEY PERSONNEL 77
COMPANY OVERVIEW 77
KEY MILESTONES 77
PRODUCTS / TECHNOLOGIES 78
RESEARCH ACTIVITIES 83
AGREEMENTS 83
KEY FINANCIAL DATA 84
COMPETITION 85
BIODELIVERY SCIENCES INTERNATIONAL 87
KEY PERSONNEL 87
COMPANY OVERVIEW 87
KEY MILESTONES 87
PRODUCTS / TECHNOLOGIES88
RESEARCH ACTIVITIES90
AGREEMENTS 91
KEY FINANCIAL DATA 92
ASSOCIATED COMPANIES 92
COMPETITION 92
BIOJECT MEDICAL TECHNOLOGIES INC 93
KEY PERSONNEL 93
COMPANY OVERVIEW 93
KEY MILESTONE 93
PRODUCTS / TECHNOLOGIES 93
RESEARCH ACTIVITIES94
AGREEMENTS96
KEY FINANCIAL DATA 97
COMPETITION 97
BIO-PATH HOLDINGS 99
KEY PERSONNEL 99
COMPANY OVERVIEW99
KEY MILESTONES 99
PRODUCTS / TECHNOLOGIES99
RESEARCH ACTIVITIES 101
AGREEMENTS 101
KEY FINANCIAL DATA 102
COMPETITION 102
BIOSANTE PHARMACEUTICALS INC 103
KEY PERSONNEL 103
COMPANY OVERVIEW 103
KEY MILESTONES 103
PRODUCTS / TECHNOLOGIES 104
RESEARCH ACTIVITIES 106
AGREEMENTS 108
KEY FINANCIAL DATA109
COMPETITION109
CALANDO PHARMACEUTICALS 111
KEY PERSONNEL111
COMPANY OVERVIEW 111
KEY MILESTONES 111
PRODUCTS / TECHNOLOGIES 111
RESEARCH ACTIVITIES 113
AGREEMENTS 113
KEY FINANCIAL DATA 114
CAMURUS AB 115
KEY PERSONNEL115
COMPANY OVERVIEW 115
KEY MILESTONES 115
PRODUCTS / TECHNOLOGIES 116
RESEARCH ACTIVITIES 118
AGREEMENTS 119
KEY FINANCIAL DATA 119
CAREFUSION121
KEY PERSONNEL 121
COMPANY OVERVIEW 121
KEY MILESTONES 121
PRODUCTS 121
AGREEMENTS 124
KEY FINANCIAL DATA 124
COMPETITION 124
CELATOR PHARMACEUTICALS INC 125
KEY PERSONNEL 125
COMPANY OVERVIEW 125
KEY MILESTONES 125
PRODUCTS / TECHNOLOGIES 126
R&D ACTIVITIES 127
AGREEMENTS 128
KEY FINANCIAL DATA 129
CELL THERAPEUTICS INC 131
KEY PERSONNEL 131
COMPANY OVERVIEW 131
KEY MILESTONES 131
PRODUCTS / TECHNOLOGIES 132
RESEARCH ACTIVITIES 133
AGREEMENTS 135
KEY FINANCIAL DATA 136
CEPHALON137
KEY PERSONNEL 137
COMPANY OVERVIEW 137
KEY MILESTONES 137
PRODUCTS 138
R&D ACTIVITIES 139
AGREEMENTS 141
KEY FINANCIAL DATA 143
COMPETITION 143
CIPHER PHARMACEUTICALS 145
KEY PERSONNEL 145
COMPANY OVERVIEW 145
KEY MILESTONES 145
PRODUCTS/TECHNOLOGIES 146
R&D MILESTONES 147
AGREEMENTS 147
KEY FINANCIAL DATA148
COLUMBIA LABORATORIES INC 149
KEY PERSONNEL 149
COMPANY OVERVIEW 149
KEY MILESTONES 149
PRODUCTS / TECHNOLOGIES 149
RESEARCH ACTIVITIES 151
AGREEMENTS 152
KEY FINANCIAL DATA 153
COMPETITION 154
CONSORT MEDICAL PLC 155
KEY PERSONNEL 155
COMPANY OVERVIEW 155
KEY MILESTONES 155
PRODUCTS / TECHNOLOGIES 155
RESEARCH ACTIVITIES 157
AGREEMENTS 157
KEY FINANCIAL DATA 158
COMPETITION 158
CORNERSTONE THERAPEUTICS 159
KEY PERSONNEL 159
COMPANY OVERVIEW 159
KEY MILESTONES 159
PRODUCTS 160
RESEARCH ACTIVITIES 161
AGREEMENTS 162
KEY FINANCIAL DATA 162
CPEX PHARMACEUTICALS INC 163
KEY PERSONNEL 163
COMPANY OVERVIEW 163
KEY MILESTONES 163
PRODUCTS / TECHNOLOGIES 164
RESEARCH ACTIVITIES 164
AGREEMENTS 165
KEY FINANCIAL DATA166
COMPETITION166
DEBIOPHARM SA 167
KEY PERSONNEL 167
COMPANY OVERVIEW 167
KEY MILESTONES 167
PRODUCTS / TECHNOLOGIES 168
RESEARCH ACTIVITIES 169
AGREEMENTS 170
KEY FINANCIAL DATA 171
ASSOCIATED COMPANIES 171
DELCATH SYSTEMS INC173
KEY PERSONNEL 173
COMPANY OVERVIEW 173
KEY MILESTONES 173
RESEARCH ACTIVITIES 174
AGREEMENTS 176
KEY FINANCIAL DATA 176
COMPETITION 177
DEPOMED INC179
KEY PERSONNEL 179
COMPANY OVERVIEW 179
KEY MILESTONES 179
PRODUCTS / TECHNOLOGIES 180
RESEARCH ACTIVITIES 181
AGREEMENTS 182
KEY FINANCIAL DATA 183
COMPETITION 183
DURECT CORPORATION 185
KEY PERSONNEL 185
COMPANY OVERVIEW 185
KEY MILESTONES 185
PRODUCTS / TECHNOLOGIES 186
AGREEMENTS 190
KEY FINANCIAL DATA 191
ASSOCIATED COMPANIES 191
COMPETITION 192
DUSA PHARMACEUTICALS INC 193
KEY PERSONNEL 193
COMPANY OVERVIEW 193
PRODUCTS / TECHNOLOGIES 193
RESEARCH ACTIVITIES 194
AGREEMENTS 195
KEY FINANCIAL DATA196
COMPETITION196
ECHO THERAPEUTICS197
KEY PERSONNEL 197
COMPANY OVERVIEW 197
KEY MILESTONES 197
PRODUCTS / TECHNOLOGIES 197
RESEARCH ACTIVITIES 199
AGREEMENTS 200
KEY FINANCIAL DATA201
COMPETITION201
ELITE PHARMACEUTICALS INC 203
KEY PERSONNEL 203
COMPANY OVERVIEW 203
KEY MILESTONES203
PRODUCTS / TECHNOLOGIES 204
RESEARCH ACTIVITIES 204
AGREEMENTS 205
KEY FINANCIAL DATA206
COMPETITION206
EGEN INC 207
KEY PERSONNEL 207
COMPANY OVERVIEW 207
PRODUCTS/TECHNOLOGIES 207
RESEARCH ACTIVITIES 208
AGREEMENTS 209
KEY FINANCIAL DATA209
EMISPHERE TECHNOLOGIES INC 211
KEY PERSONNEL211
COMPANY OVERVIEW 211
KEY MILESTONES 211
PRODUCTS / TECHNOLOGIES 211
RESEARCH ACTIVITIES 215
AGREEMENTS 215
KEY FINANCIAL DATA 216
COMPETITION 216
ENCAP DRUG DELIVERY 217
KEY PERSONNEL 217
COMPANY OVERVIEW 217
PRODUCTS / TECHNOLOGIES 217
AGREEMENTS 219
KEY FINANCIAL DATA 219
ENDO PHARMACEUTICALS 221
KEY PERSONNEL 221
COMPANY OVERVIEW 221
KEY MILESTONES221
TECHNOLOGIES/PRODUCTS 222
R&D MILESTONES (Endo) 227
AGREEMENTS 229
AGREEMENTS (Penwest)230
COMPETITION230
KEY FINANCIAL DATA 231
ENDOCYTE 233
KEY PERSONNEL 233
COMPANY OVERVIEW 233
KEY MILESTONES233
PRODUCTS / TECHNOLOGIES 233
RESEARCH ACTIVITIES 234
AGREEMENTS 236
KEY FINANCIAL DATA236
ENZON INC 237
KEY PERSONNEL 237
COMPANY OVERVIEW 237
KEY MILESTONES237
PRODUCTS / TECHNOLOGIES 238
RESEARCH ACTIVITIES 239
KEY FINANCIAL DATA 241
COMPETITION242
EPEIUS BIOTECHNOLOGIES INC 243
KEY PERSONNEL 243
COMPANY OVERVIEW 243
KEY MILESTONES243
PRODUCTS/TECHNOLOGIES 244
RESEARCH ACTIVITIES 245
KEY FINANCIAL DATA246
COMPETITION246
ETHYPHARM S/A 249
KEY PERSONNEL 249
COMPANY OVERVIEW 249
KEY MILESTONES249
PRODUCTS / TECHNOLOGIES 249
RESEARCH ACTIVITIES 252
AGREEMENTS 252
KEY FINANCIAL DATA253
FLAMEL TECHNOLOGIES INC 255
KEY PERSONNEL 255
COMPANY OVERVIEW 255
PRODUCTS / TECHNOLOGIES 255
R&D ACTIVITIES258
AGREEMENTS 259
KEY FINANCIAL DATA260
COMPETITION260
FZIOMED INC 261
KEY PERSONNEL 261
COMPANY OVERVIEW 261
KEY MILESTONES 261
PRODUCTS / TECHNOLOGIES 261
RESEARCH ACTIVITIES 263
KEY FINANCIAL DATA264
GENEREX BIOTECHNOLOGY CORPORATION 265
KEY PERSONNEL 265
COMPANY OVERVIEW 265
KEY MILESTONES265
PRODUCTS / TECHNOLOGIES 266
RESEARCH ACTIVITIES 267
AGREEMENTS 270
KEY FINANCIAL DATA271
COMPETITION272
GILEAD SCIENCES 273
KEY PERSONNEL 273
COMPANY OVERVIEW 273
KEY MILESTONES273
PRODUCTS / TECHNOLOGIES 274
RESEARCH ACTIVITIES 277
AGREEMENTS 282
KEY FINANCIAL DATA284
HOSPIRA 285
KEY PERSONNEL 285
COMPANY OVERVIEW 285
KEY MILESTONES285
PRODUCTS / TECHNOLOGIES 286
RESEARCH ACTIVITIES 289
AGREEMENTS 290
KEY FINANCIAL DATA291
IMMUNOGEN 293
KEY PERSONNEL 293
COMPANY OVERVIEW 293
KEY MILESTONES293
PRODUCTS / TECHNOLOGIES 293
RESEARCH ACTIVITIES 294
AGREEMENTS 297
KEY FINANCIAL DATA298
IMPAX LABORATORIES 299
KEY PERSONNEL 299
COMPANY OVERVIEW 299
KEY MILESTONES299
PRODUCTS / TECHNOLOGIES 300
RESEARCH ACTIVITIES 302
AGREEMENTS 303
KEY FINANCIAL DATA304
COMPETITION304
INNOCOLL TECHNOLOGIES 305
KEY PERSONNEL 305
COMPANY OVERVIEW 305
KEY MILESTONES305
PRODUCTS / TECHNOLOGIES 305
RESEARCH ACTIVITIES 307
AGREEMENTS 309
KEY FINANCIAL DATA 310
INOVIO PHARMACEUTICALS 311
KEY PERSONNEL311
COMPANY OVERVIEW 311
KEY MILESTONES 311
TECHNOLOGIES / PRODUCTS 311
RESEARCH ACTIVITIES 312
AGREEMENTS 315
KEY FINANCIAL DATA 317
KEY COMPETITION 317
INSITE VISION INC319
KEY PERSONNEL 319
COMPANY OVERVIEW 319
KEY MILESTONES 319
PRODUCTS / TECHNOLOGIES 319
RESEARCH ACTIVITIES 321
AGREEMENTS 323
KEY FINANCIAL DATA324
COMPETITION324
INSYS THERAPEUTICS 325
KEY PERSONNEL 325
COMPANY OVERVIEW 325
KEY MILESTONES325
PRODUCTS / TECHNOLOGIES 326
AGREEMENTS 328
KEY FINANCIAL DATA329
INTELGENX CORPORATION331
KEY PERSONNEL 331
COMPANY OVERVIEW 331
KEY MILESTONES 331
PRODUCTS / TECHNOLOGIES 332
RESEARCH ACTIVITIES 333
AGREEMENTS 334
KEY FINANCIAL DATA336
COMPETITION336
INTERCELL AG 337
KEY PERSONNEL 337
COMPANY OVERVIEW 337
KEY MILESTONES 337
PRODUCTS / TECHNOLOGIES 338
RESEARCH ACTIVITIES 339
AGREEMENTS 342
KEY FINANCIAL DATA342
COMPETITION343
KV PHARMACEUTICAL COMPANY 345
KEY PERSONNEL 345
COMPANY OVERVIEW 345
KEY MILESTONES345
PRODUCTS / TECHNOLOGIES 346
AGREEMENTS 348
KEY FINANCIAL DATA349
COMPETITION349
LAVIPHARM GROUP351
KEY PERSONNEL 351
COMPANY OVERVIEW 351
KEY MILESTONES 351
PRODUCTS / TECHNOLOGIES 351
AGREEMENTS 353
KEY FINANCIAL DATA354
LIGHT SCIENCES ONCOLOGY 355
KEY PERSONNEL 355
COMPANY OVERVIEW 355
PRODUCTS / TECHNOLOGIES 355
RESEARCH ACTIVITIES 356
AGREEMENTS 358
KEY FINANCIAL DATA358
MANNKIND CORPORATION 359
KEY PERSONNEL 359
COMPANY OVERVIEW 359
KEY MILESTONES359
PRODUCTS / TECHNOLOGIES 360
RESEARCH ACTIVITIES 362
AGREEMENTS 364
KEY FINANCIAL DATA365
COMPETITION365
Marina Biotech 367
KEY PERSONNEL 367
COMPANY OVERVIEW 367
KEY MILESTONES367
PRODUCTS / TECHNOLOGIES 368
RESEARCH ACTIVITIES 369
AGREEMENTS 372
KEY FINANCIAL DATA373
COMPETITION 374
MAXCYTE INC 375
KEY PERSONNEL 375
COMPANY OVERVIEW 375
PRODUCTS / TECHNOLOGIES 375
AGREEMENTS 377
KEY FINANCIAL DATA377
MEDIMMUNE INC 379
KEY PERSONNEL 379
COMPANY OVERVIEW 379
KEY MILESTONES379
PRODUCTS / TECHNOLOGIES 380
RESEARCH ACTIVITIES 381
AGREEMENTS 382
KEY FINANCIAL DATA383
COMPETITION383
MILESTONE SCIENTIFIC 385
KEY PERSONNEL 385
COMPANY BACKGROUND 385
KEY MILESTONES385
PRODUCTS / TECHNOLOGIES 385
AGREEMENTS 387
KEY FINANCIAL DATA388
COMPETITION388
MOOG MEDICAL DEVICES 389
KEY PERSONNEL 389
COMPANY OVERVIEW 389
KEY MILESTONES389
PRODUCTS / TECHNOLOGIES 389
AGREEMENTS 390
KEY FINANCIAL DATA 391
NANOBIOTIX 393
KEY PERSONNEL 393
COMPANY OVERVIEW 393
PRODUCTS / TECHNOLOGIES 393
RESEARCH ACTIVITIES 394
AGREEMENTS 394
KEY FINANCIAL DATA395
NANOMATERIALS TECHNOLOGY 397
KEY PERSONNEL 397
COMPANY OVERVIEW 397
KEY MILESTONES397
PRODUCTS / TECHNOLOGIES 397
AGREEMENTS 398
KEY FINANCIAL DATA398
NANOBIO CORPORATION 399
KEY PERSONNEL 399
COMPANY OVERVIEW 399
KEY MILESTONES399
PRODUCTS / TECHNOLOGIES 400
RESEARCH ACTIVITIES 401
AGREEMENTS 403
KEY FINANCIAL DATA404
NANOBIOMAGNETICS 405
KEY PERSONNEL 405
COMPANY OVERVIEW 405
PRODUCTS / TECHNOLOGIES 405
AGREEMENTS 406
KEY FINANCIAL DATA406
ASSOCIATED COMPANIES 407
NANOCARRIER 409
KEY PERSONNEL 409
COMPANY OVERVIEW 409
PRODUCTS / TECHNOLOGIES 409
RESEARCH ACTIVITIES 410
AGREEMENTS 411
KEY FINANCIAL DATA 413
NANOTHERAPEUTICS INC 415
KEY PERSONNEL 415
COMPANY OVERVIEW 415
KEY MILESTONES 415
PRODUCTS / TECHNOLOGIES 416
RESEARCH ACTIVITIES 419
AGREEMENTS 420
KEY FINANCIAL DATA 421
NEKTAR THERAPEUTICS 423
KEY PERSONNEL 423
COMPANY OVERVIEW 423
KEY MILESTONES423
PRODUCTS / TECHNOLOGIES 424
RESEARCH ACTIVITIES 425
AGREEMENTS 429
KEY FINANCIAL DATA430
ASSOCIATED COMPANIES 431
COMPETITION 431
NEUROGESX 433
KEY PERSONNEL 433
COMPANY OVERVIEW 433
KEY MILESTONES433
PRODUCTS / TECHNOLOGIES 433
RESEARCH STRATEGY 434
AGREEMENTS 434
KEY FINANCIAL DATA435
COMPETITION435
NEUROTECH 437
KEY PERSONNEL 437
COMPANY OVERVIEW 437
KEY MILESTONES437
PRODUCTS / TECHNOLOGIES 437
RESEARCH ACTIVITIES 439
AGREEMENTS 439
KEY FINANCIAL DATA440
ASSOCIATED COMPANIES 440
NOVADEL PHARMA 441
KEY PERSONNEL 441
COMPANY OVERVIEW 441
KEY MILESTONES441
PRODUCTS / TECHNOLOGIES 441
RESEARCH ACTIVITIES 442
AGREEMENTS 444
KEY FINANCIAL DATA445
COMPETITION445
NOVAVAX 447
KEY PERSONNEL 447
COMPANY OVERVIEW 447
KEY MILESTONES447
PRODUCTS / TECHNOLOGIES 448
RESEARCH ACTIVITIES 448
AGREEMENTS 451
KEY FINANCIAL DATA453
COMPETITION453
NOVEN PHARMACEUTICALS 455
KEY PERSONNEL 455
COMPANY OVERVIEW 455
KEY MILESTONES455
PRODUCTS / TECHNOLOGIES 455
RESEARCH ACTIVITIES 457
AGREEMENTS 457
KEY FINANCIAL DATA458
COMPETITION458
OCTOPLUS 459
KEY PERSONNEL 459
COMPANY OVERVIEW 459
KEY MILESTONES459
PRODUCTS / TECHNOLOGIES 459
AGREEMENTS 462
KEY FINANCIAL DATA463
OREXO 465
KEY PERSONNEL 465
COMPANY OVERVIEW 465
KEY MILESTONES465
PRODUCTS / TECHNOLOGIES 466
RESEARCH ACTIVITIES 469
AGREEMENTS 472
KEY FINANCIAL DATA473
COMPETITION 473
OTSUKA HOLDINGS475
KEY PERSONNEL 475
COMPANY OVERVIEW 475
KEY MILESTONES 475
PRODUCTS / TECHNOLOGIES 475
RESEARCH ACTIVITIES 480
AGREEMENTS 482
KEY FINANCIAL DATA483
PACIRA PHARMACEUTICALS INC 485
KEY PERSONNEL 485
COMPANY OVERVIEW 485
KEY MILESTONES485
PRODUCTS / TECHNOLOGIES 486
RESEARCH ACTIVITIES 487
AGREEMENTS 489
KEY FINANCIAL DATA489
COMPETITION489
PCI BIOTECH 491
KEY PERSONNEL 491
COMPANY OVERVIEW 491
KEY MILESTONES491
PRODUCTS / TECHNOLOGIES 491
RESEARCH ACTIVITIES 492
AGREEMENTS 493
KEY FINANCIAL DATA493
PEARL THERAPEUTICS 495
KEY PERSONNEL 495
COMPANY OVERVIEW 495
PRODUCTS / TECHNOLOGIES 495
RESEARCH STRATEGY 497
KEY FINANCIAL DATA498
PHOSPHAGENICS LIMITED 499
KEY PERSONNEL 499
COMPANY OVERVIEW 499
KEY MILESTONES499
TECHNOLOGIES / PRODUCTS 499
RESEARCH ACTIVITIES 502
AGREEMENTS 503
FINANCIALS 504
PHOTOCURE ASA 505
KEY PERSONNEL 505
COMPANY OVERVIEW 505
KEY MILESTONES505
PRODUCTS / TECHNOLOGIES 506
RESEARCH ACTIVITIES 507
AGREEMENTS 509
KEY FINANCIAL DATA 510
ASSOCIATED COMPANIES 510
POLYTHERICS LTD511
KEY PERSONNEL511
COMPANY OVERVIEW 511
KEY MILESTONES 511
PRODUCTS / TECHNOLOGIES 511
PRODUCTS 512
AGREEMENTS 513
KEY FINANCIAL DATA 514
pSIVIDA 515
KEY PERSONNEL 515
COMPANY OVERVIEW 515
KEY MILESTONES 515
TECHNOLOGIES / PRODUCTS 516
RESEARCH ACTIVITIES 517
AGREEMENTS 519
KEY FINANCIAL DATA 521
QLT 523
KEY PERSONNEL 523
COMPANY OVERVIEW 523
KEY MILESTONES523
PRODUCTS / TECHNOLOGIES 523
RESEARCH ACTIVITIES 524
AGREEMENTS 526
KEY FINANCIAL DATA527
COMPETITION527
QUEST PHARMATECH 529
KEY PERSONNEL 529
COMPANY OVERVIEW 529
KEY MILESTONES529
PRODUCTS / TECHNOLOGIES 529
RESEARCH ACTIVITIES 530
AGREEMENTS 531
KEY FINANCIAL DATA532
RAPTOR PHARMACEUTICALS 533
KEY PERSONNEL 533
COMPANY OVERVIEW 533
KEY MILESTONES533
PRODUCTS / TECHNOLOGIES 534
RESEARCH ACTIVITIES 536
AGREEMENTS 539
KEY FINANCIAL DATA540
COMPETITION540
RETRACTABLE TECHNOLOGIES INC 543
KEY PERSONNEL 543
COMPANY OVERVIEW 543
PRODUCTS / TECHNOLOGIES 543
LITIGATION UPDATE 544
KEY FINANCIAL DATA544
COMPETITION545
SAVARA PHARMACEUTICALS INC 547
KEY PERSONNEL 547
COMPANY OVERVIEW 547
KEY MILESTONES547
PRODUCTS / TECHNOLOGIES 548
KEY FINANCIAL DATA549
SCOLR PHARMA INC 551
KEY PERSONNEL 551
COMPANY OVERVIEW 551
KEY MILESTONES 551
PRODUCTS / TECHNOLOGIES 551
RESEARCH ACTIVITIES 552
AGREEMENTS 553
KEY FINANCIAL DATA554
COMPETITION554
SEATTLE GENETICS 555
KEY PERSONNEL 555
COMPANY OVERVIEW 555
KEY MILESTONES555
PRODUCTS / TECHNOLOGIES 556
RESEARCH ACTIVITIES 556
AGREEMENTS 560
KEY FINANCIAL DATA 561
COMPETITION562
SILENCE THERAPEUTICS 563
KEY PERSONNEL 563
COMPANY OVERVIEW 563
KEY MILESTONES563
PRODUCTS / TECHNOLOGIES 563
RESEARCH ACTIVITIES 564
AGREEMENTS 565
KEY FINANCIAL DATA566
SKINVISIBLE INC 567
KEY PERSONNEL 567
COMPANY OVERVIEW 567
KEY MILESTONES567
PRODUCTS / TECHNOLOGIES 567
RESEARCH ACTIVITIES 568
AGREEMENTS 569
KEY FINANCIAL DATA570
COMPETITION570
SKYEPHARMA PLC 573
KEY PERSONNEL 573
COMPANY OVERVIEW 573
KEY MILESTONES573
PRODUCTS / TECHNOLOGIES 574
RESEARCH ACTIVITIES 579
AGREEMENTS 581
KEY FINANCIAL DATA582
ASSOCIATED COMPANIES 582
COMPETITION582
SOLIGENIX 583
KEY PERSONNEL 583
COMPANY OVERVIEW 583
KEY MILESTONES583
PRODUCTS / TECHNOLOGIES 584
RESEARCH ACTIVITIES 587
AGREEMENTS 589
KEY FINANCIAL DATA590
COMPETITION590
STARPHARMA 593
KEY PERSONNEL 593
COMPANY OVERVIEW 593
KEY MILESTONES593
PRODUCTS / TECHNOLOGIES 593
RESEARCH ACTIVITIES 594
AGREEMENTS 596
KEY FINANCIAL DATA597
SUPRATEK PHARMA INC 599
KEY PERSONNEL 599
COMPANY OVERVIEW 599
KEY MILESTONES599
PRODUCTS / TECHNOLOGIES 599
RESEARCH ACTIVITIES 601
KEY FINANCIAL DATA601
TEKMIRA PHARMACEUTICALS CORPORATION 603
KEY PERSONNEL 603
COMPANY OVERVIEW 603
KEY MILESTONES603
PRODUCTS / TECHNOLOGIES 604
RESEARCH ACTIVITIES 606
AGREEMENTS 609
KEY FINANCIAL DATA 610
TELESSO TECHNOLOGIES611
KEY PERSONNEL611
COMPANY OVERVIEW 611
KEY MILESTONES 611
PRODUCTS / TECHNOLOGIES 611
RESEARCH ACTIVITIES 614
AGREEMENTS 615
KEY FINANCIAL DATA 615
ASSOCIATED COMPANIES 615
TRANSPHARMA MEDICAL 617
KEY PERSONNEL 617
COMPANY OVERVIEW 617
KEY MILESTONES 617
PRODUCTS / TECHNOLOGIES 617
RESEARCH ACTIVITIES 619
AGREEMENTS 621
KEY FINANCIAL DATA 621
TRIMEL PHARMACEUTICALS 623
KEY PERSONNEL 623
COMPANY OVERVIEW 623
KEY MILESTONES623
PRODUCTS / TECHNOLOGIES 623
RESEARCH ACTIVITIES 625
KEY FINANCIAL DATA626
COMPETITION626
UNILIFE 627
KEY PERSONNEL 627
COMPANY OVERVIEW 627
KEY MILESTONES627
PRODUCTS / TECHNOLOGIES 628
RESEARCH ACTIVITIES 629
AGREEMENTS 630
KEY FINANCIAL DATA630
COMPETITION 631
VALEANT PHARMACEUTICALS 633
KEY PERSONNEL 633
COMPANY OVERVIEW 633
KEY MILESTONES633
PRODUCTS / TECHNOLOGIES 634
RESEARCH ACTIVITIES 637
AGREEMENTS 638
KEY FINANCIAL DATA640
COMPETITION641
VECTURA LTD 643
KEY PERSONNEL 643
COMPANY OVERVIEW 643
KEY MILESTONES643
PRODUCTS / TECHNOLOGIES 643
RESEARCH ACTIVITIES 645
AGREEMENTS 648
KEY FINANCIAL DATA650
ASSOCIATED COMPANIES 650
VICAL INC 651
KEY PERSONNEL 651
COMPANY OVERVIEW 651
KEY MILESTONES 651
PRODUCTS / TECHNOLOGIES 651
RESEARCH ACTIVITIES 652
AGREEMENTS 655
KEY FINANCIAL DATA656
VIVUS INC 657
KEY PERSONNEL 657
COMPANY OVERVIEW 657
KEY MILESTONES657
PRODUCTS / TECHNOLOGIES 658
RESEARCH ACTIVITIES 661
AGREEMENTS 662
KEY FINANCIAL DATA662
COMPETITION662
ZOGENIX INC 663
KEY PERSONNEL 663
COMPANY OVERVIEW 663
KEY MILESTONES663
PRODUCTS / TECHNOLOGIES 664
RESEARCH ACTIVITIES 665
AGREEMENTS 666
KEY FINANCIAL DATA666
ZOSANO PHARMA 667
KEY PERSONNEL 667
COMPANY OVERVIEW 667
PRODUCTS / TECHNOLOGIES 667
RESEARCH ACTIVITIES 668
AGREEMENTS 669
KEY FINANCIAL DATA669
To order this report:
Drug_Delivery_Technology Industry: Drug Delivery: Surveying the Global Competitive Landscape
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article